These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 24670681)
21. Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders. Smith LD; Willig LK; Kingsmore SF Cold Spring Harb Perspect Med; 2015 Dec; 6(2):a023168. PubMed ID: 26684335 [TBL] [Abstract][Full Text] [Related]
22. [Whole genome sequencing--new opportunities for health care practice?]. de Jong A; Teeuw M; Janssens AC Ned Tijdschr Geneeskd; 2010; 154():A2753. PubMed ID: 21029487 [TBL] [Abstract][Full Text] [Related]
25. Including ELSI research questions in newborn screening pilot studies. Goldenberg AJ; Lloyd-Puryear M; Brosco JP; Therrell B; Bush L; Berry S; Brower A; Bonhomme N; Bowdish B; Chrysler D; Clarke A; Crawford T; Goldman E; Hiner S; Howell RR; Orren D; Wilfond BS; Watson M; Genet Med; 2019 Mar; 21(3):525-533. PubMed ID: 30100612 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up data collection and use in state newborn screening programs. Hoff T; Ayoob M; Therrell BL Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144 [TBL] [Abstract][Full Text] [Related]
27. Waiving informed consent in newborn screening research: balancing social value and respect. Tarini BA; Burke W; Scott CR; Wilfond BS Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):23-30. PubMed ID: 18200521 [TBL] [Abstract][Full Text] [Related]
28. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Chou J; Ohsumi TK; Geha RS Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910 [TBL] [Abstract][Full Text] [Related]
29. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States. Wilfond BS; Gollust SE J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672 [TBL] [Abstract][Full Text] [Related]
30. [Genomic newborn screening. Perspective from the Ethics Commission of the Spanish Society for Human Genetics. Part II: Ethical, legal and social issues (ELSIs) of the introduction of next generation sequencing technologies in a public health newborn screening program.]. Pàmpols Ros T; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Blanco Guillermo I Rev Esp Salud Publica; 2022 Mar; 96():. PubMed ID: 35283479 [TBL] [Abstract][Full Text] [Related]
31. Commercial Interests, the Technological Imperative, and Advocates: Three Forces Driving Genomic Sequencing in Newborns. Pereira S; Clayton EW Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S43-S44. PubMed ID: 30133724 [TBL] [Abstract][Full Text] [Related]
32. European best practice guidelines for cystic fibrosis neonatal screening. Castellani C; Southern KW; Brownlee K; Dankert Roelse J; Duff A; Farrell M; Mehta A; Munck A; Pollitt R; Sermet-Gaudelus I; Wilcken B; Ballmann M; Corbetta C; de Monestrol I; Farrell P; Feilcke M; Férec C; Gartner S; Gaskin K; Hammermann J; Kashirskaya N; Loeber G; Macek M; Mehta G; Reiman A; Rizzotti P; Sammon A; Sands D; Smyth A; Sommerburg O; Torresani T; Travert G; Vernooij A; Elborn S J Cyst Fibros; 2009 May; 8(3):153-73. PubMed ID: 19246252 [TBL] [Abstract][Full Text] [Related]
33. Inborn errors of metabolism and expanded newborn screening: review and update. Mak CM; Lee HC; Chan AY; Lam CW Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058 [TBL] [Abstract][Full Text] [Related]
34. Public views on participating in newborn screening using genome sequencing. Bombard Y; Miller FA; Hayeems RZ; Barg C; Cressman C; Carroll JC; Wilson BJ; Little J; Avard D; Painter-Main M; Allanson J; Giguere Y; Chakraborty P Eur J Hum Genet; 2014 Nov; 22(11):1248-54. PubMed ID: 24549052 [TBL] [Abstract][Full Text] [Related]
35. Ethical problems with neonatal screening. Orzalesi M; Danhaive O Ann Ist Super Sanita; 2009; 45(3):325-30. PubMed ID: 19861738 [TBL] [Abstract][Full Text] [Related]